LULU heads into its June 4 earnings print with short sellers at their most active in months — and analysts slashing targets even as the stock bounced hard off its lows.
Short interest has climbed nearly 44% over the past month to around 6% of the free float, the highest level in the 30-day dataset and a sharp acceleration from the 4.1% reading in mid-April. That's a meaningful build: sellers added roughly 2 million shares net in five weeks, pushing estimated shorts above 6.3 million. The pace of rebuilding is the story here, not the absolute level — LULU is not a crowded short by any means, but the direction of travel is unambiguous heading into a binary catalyst. The ORTEX short score of 43 sits in roughly the middle of the range, consistent with a stock where pressure is building but not yet extreme.
The lending market does not suggest stress. Availability is ample at around 748% of short interest, meaning there are roughly seven-and-a-half shares available to borrow for every share already short. Cost to borrow has eased to 0.33% — down about 16% on the week — and the 52-week peak availability was over 2,000%, so the current level, while tighter than April norms, is well within comfortable territory. There is no squeeze dynamic in the borrow market. Options are similarly unalarmed: the put/call ratio of 0.77 is actually below its 20-day average of 0.82, about 1.2 standard deviations on the call-heavy side, suggesting options traders are not piling into protection ahead of the print.
The Street, however, is clearly less comfortable. Analysts have been cutting targets in a near-uniform direction. Piper Sandler dropped its target from $190 to $130 last week, keeping a Neutral rating. Baird trimmed from $190 to $170 earlier this month. The broader wave of downgrades from March — JPMorgan, UBS, Wells Fargo, Citigroup, Stifel, Truist and BNP Paribas all lowering while holding neutral or hold ratings — has left the consensus firmly in "wait and see" mode with only two buy-rated analysts in the count. The mean targets from those March actions ($150–$196 range) now sit 18–54% above the current price of $127, which looks optimistic given the recent trajectory, but the discrepancy partly reflects how fast the stock has fallen. The bear case is clear: fixed cost deleverage, tariff exposure, Americas sales under pressure, and store traffic declining. The bull case rests on pricing power, international expansion, and the hope that Q1 beats — which, per a recent note, the company did deliver — signal a bottom.
Valuation has compressed with the stock. The P/E is running near 10x and EV/EBITDA near 5.7x — modest multiples for a brand that traded at premium apparel valuations not long ago. The P/B has fallen to 2.5x, down about 0.4 turns over the past month. Factor scores reflect the tension: EPS momentum at 42 and forward EPS growth rank at 34 point to muted near-term expectations, while the momentum score benefits from the recent bounce — the stock is up 6.8% on the week, clawing back some of an 11.4% monthly decline. Peer comparison echoes the apparel sector's broader relief rally: RL and DECK both rose around 17–18% on the week, outpacing LULU's recovery, while ONON and CPRI lagged with gains of roughly 5–6%.
Earnings history provides modest context. The last print (March 17) delivered a 3.4% one-day gain but faded to near flat over five days. The prior event saw a 3.7% one-day drop with a partial recovery over the following week. Two data points don't make a pattern, but neither suggests the market has been rewarding LULU decisively on results. With the June 4 announcement now less than two weeks away, what matters most is whether Americas comps have stabilised and whether management narrows the tariff uncertainty that has weighed on the margin outlook. Short sellers are building positions into the event; options traders are not.
See the live data behind this article on ORTEX.
Open LULU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
